KDNG News Alert Kading Co's Sa (KDNG) 0.1500 02/15/2015 00:5

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kading Co's Sa (KDNG) 0.1500 $KDNG

Kading Companies Announces the Signing of an Acquisition Agreement between Kading Companies and System Cement Group, Inc.
Business Wire - Thu Jan 29, 9:30AM CST
Kading Companies, S.A. (OTC:KDNG), announces the signing of an acquisition agreement to acquire 70% of a profitable cement manufacturer - System Cement Group, which owns 100% of SCG - Ukraine, LLC located in Vinnitsa, Ukraine

Kading Companies Announces the Signing of Their First Sale and Purchase Agreement with Chief Nana Kwaku Baah II, a Producing Gold Mining Organization Based in Ghana, West Africa
Business Wire - Tue Dec 02, 10:05AM CST
Kading Companies, S.A. (OTC: KDNG), announces the signing of a twelve month joint venture sale and purchase agreement with Chief Nana Kwaku Baah II whereby Kading Companies will purchase 100 kilos of gold dore per month commencing in early January 2015. Kading Companies will buy the gold dore at a discount to the spot price whereby Kading Companies expects to gross 50% of the net proceeds of the sale of the gold dore.

Kading Companies Announces the Completion of Its August 31, 2014 Fiscal Year-End Financial Statements
Business Wire - Thu Oct 30, 8:01AM CDT
Kading Companies, S.A. (OTC:KDNG), announces the completion of its August 31, 2014 fiscal year-end financial statements that are posted at www.kadingcompanies.com. Now that Kading Companies is current with its financial statements we will be compiling the necessary due diligence to move the Company back to Current Information status on the OTCMarkets.com.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading